Compared with standard therapy, our findings indicated that the combined use of PD-1/L1 inhibitors, anti-VEGF antibody, and chemotherapy as the initial treatment showed significant potential in suppressing tumor growth. The gene discussed is PDCD1; the disease is neoplasm.